Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable (IV)-59 (IGLVIV-59) is a pseudogene within the immunoglobulin lambda light chain variable region gene family on chromosome 22. Immunoglobulin variable (V) region gene segments, including functional genes and pseudogenes, provide the raw genetic material for the diversity of antigen-binding sites in antibodies. However, as a pseudogene, IGLVIV-59 does not encode a functional protein product and is not transcribed into a complete immunoglobulin light chain. Such pseudogenes are a common feature in the immunoglobulin loci, reflecting the evolutionary mechanisms that generate antibody diversity[1][3]. There is no evidence of this gene being a target for therapeutics, a direct contributor to disease etiology, or a source of clinical biomarker information[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable (IV)-59 (pseudogene) (IGLVIV-59).